Proton magnetic resonance spectroscopy in dementia of Alzheimer type

International Journal of Geriatric Psychiatry

Volumn 12, Issue 3, 1997, Pages 349-358

  Heun, Reinhard ^a,b   Schlegel, Sabine ^a   Graf Morgenstern, Mechthild ^a   Tintera, Jaroslav ^a   Gawehn, Joachim ^a   Stoeter, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Choline; Creatine; Dementia; Magnetic resonance spectroscopy; Myo inositol; N acetyl aspartate; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOLOGIC TEST;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; FEMALE; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0030939128     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1166(199703)12:3<349::AID-GPS508>3.0.CO;2-S     Document Type: Article

References (62)

1. Altman, D. G. (1991) Practical Statistics for Medical Research. Chapman & Hall, London.
2. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. American Psychiatric Association, Washington, DC.
3. Barany, M., Spigos, D. G., Mok, E., Venkatasubramanian, P. N., Wilbur, A. C. and Langer, B. G. (1987) High resolution proton magnetic resonance spectroscopy of human brain and liver. Magn. Reson. Imag. 5, 393-398.
4. 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13, 23-31.
5. Blessed, G., Tomlinson, B. E. and Roth, M. (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Brit. J. Psychiat. 114, 797-811.
6. Brown, G. G., Garcia, J. H., Gdowski, J. W., Levine, S. R. and Helpern, J. A. (1993) Altered brain energy metabolism in demented patients with multiple subcortical ischemic lesions. Arch. Neurol. 50, 384-388.
7. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates. Biol. Psychiat. 36, 792-800.
8. Burri, R., Steffen, C. and Herschkowitz, N. (1991) N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. Dev. Neurosci. 13, 403-411.
9. Buschke, H. and Fuld, P. A. (1974) Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24, 1019-1025.
10. Chong, W. K., Paley, M., Wilkinson, I. D., Hall-Craggs, M. A., Sweeney, B., Harrison, M. J. G., Miller, R. F. and Kendall, B. E. (1994) Localized cerebral proton MR spectroscopy in HIV infection and AIDS. Am. J. Neuroradiol. 15, 21-25.
11. Christiansen, P., Toft, P., Larsson, H. B. W., Stubgaard, M. and Henriksen, O. (1993) The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn. Reson. Imag. 11, 799-806.
12. Confort-Gouny, S., Vion-Dury, J., Nicoli, F., Dano, P., Donnet, A., Grazziani, N., Gastaut, J. L., Grisoli, F. and Cozzone, P. J. (1993) A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases. J. Neurol. Sci. 118, 123-133.
13. D'Adamo, A. F., Gidez, L. I. and Yatsu, F. M. (1968) Acetyl transport mechanisms. Involvement of N-acetyl aspartic acid in de novo fatty acid biosynthesis in the developing rat brain. Exp. Brain Res. 5, 267-273.
14. Den Hollander, J. A. (1986) In vivo tissue analysis by NMR spectroscopy. Diagn. Imag. Clin. Med. 55, 9-19.
15. Erecinska, M. and Silver, I. A. (1989) ATP and brain function. J. Cereb. Blood Flow Metab. 9, 2-19.
16. Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975) 'Mini-Mental State'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 12, 189-198.
17. Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hänicke, W. and Sauter, R. (1989) Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn. Reson. Med. 11, 47-63.
18. Frahm, J., Bruhn, H., Michaelis, T., Merboldt, K. D., Hänicke, W. and Gyngell, M. L. (1991) Lokalisierte Protonen-MR-Spektroskopie. Nichtinvasive Einblicke in den Hirnstoffwechsel. Radiologe 31, 558-566.
19. Gadian, D. G. (1993) Advances in proton magnetic resonance spectroscopy of the brain. Magn. Reson. Med. 30, 1-3.
20. Graham, S. H., Meyerhoff, D. J., Bayne, L., Sharp, F. R. and Weiner, M. W. (1994) Magnetic resonance spectroscopy of N-acetylaspartate in hypoxic-ischemic encephalopathy. Ann. Neurol. 35, 490-494.
21. Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R. and Symon, L. (1975) Cerebral blood flow in dementia. Arch. Neurol. 32, 632-637.
22. Häussinger, D., Laubenberger, J., vom Dahl, S., Ernst, T., Bayer, S., Langer, M., Gerok, W. and Hennig, J. (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 107, 1475-1480.
23. 1H spectroscopy of the human brain at 1.5 tesla. Acta Radiol. 31, 181-186.
24. 1H spectroscopic imaging. Ann. Neurol. 36, 157-165.
25. Isaacs, B. and Kennie, A. T. (1973) The Set test as an aid to the detection of dementia in old people. Brit. J. Psychiat. 123, 467-470.
26. 1H in vivo NMR spectroscopy of small-volume elements in human brain at 1.5 T. Magn. Reson. Med. 15, 320-326.
27. 1H nuclear magnetic resonance spectroscopy identifies neural cell types: A promising step for neuroimaging? TINS 16, 384-386.
28. Kauppinen, R. A., Williams, S. R., Busza, A. L. and van Bruggen, N. (1993) Applications of magnetic resonance spectroscopy and diffusion-weighted imaging to the study of brain biochemistry and pathology. TINS 16, 88-95.
29. Keshavan, M. S., Kapur, S. and Pettegrew, J. W. (1991) Magnetic resonance spectroscopy in psychiatry: Potential, pitfalls and promise 1991. Am. J. Psychiat. 148, 976-985.
30. Klunk, W. E., Panchalingam, K., Moossy, J., McClure, R. J. and Pettegrew, J. W. (1992) N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer's disease brain: A preliminary proton nuclear magnetic resonance study. Neurology 42, 1578-1585.
31. Kofmann, O., Belmaker, R. H., Grisaru, N., Alpert, C., Fuchs, I., Katz, V. and Rigler, O. (1991) Myo-inositol attenuates two specific behavioral effects of acute lithium in rats. Psychopharmacol. Bull. 27, 185-190.
32. 1. Radiology 184, 123-130.
33. Kreis, R., Ross, B. D., Farrow, N. A. and Ackerman, Z. (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182, 19-27.
34. Kruse, B., Hanefeld, F., Christen, H. J., Bruhn, H., Michaelis, T., Hänicke, W. and Frahm, J. (1993) Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo. J. Neurol. 241, 68-74.
35. Lock, T., Abou-Saleh, M. T. and Edwards, R. H. T. (1990) Psychiatry and the new magnetic resonance era. Brit. J. Psychiat, 157 (Suppl. 9), 38-55.
36. Luyten, P. R., Marien, A. J. H. and den Hollander, J. A. (1991) Acquisition and quantitation in proton spectroscopy. NMR Biomed. 4, 64-69.
37. McGeer, P. L., Eccles, C. and McGeer, E. G. (1987) Molecular Neurobiology of the Mammalian Brain. Plenum, New York.
38. Meyerhoff, D. J., MacKay, S., Constans, J.-M., Norman, D., Van Dyke, C., Fein, G. and Weiner, M.W. (1994) Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann. Neurol. 36, 40-47.
39. 31PNMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease. Can. J. Neurol. Sci. 13, 535-539.
40. 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 4, 47-52.
41. Miller, B. L., Moats, R. A., Shonk, T., Ernst, T., Woolley, S. and Ross, B. D. (1993) Alzheimer disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 187, 433-437.
42. Moats, R. A., Ernst, T., Shonk, T. K. and Ross, B. D. (1994) Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn. Reson. Med. 32, 110-115.
43. Narayana, P. A., Johnston, D. and Flamig, D. P. (1991) In vivo proton magnetic resonance spectroscopy studies of human brain. Magn. Reson. Imag. 9, 303-308.
44. 1H MRS) of the hippocampal formation in schizophrenia: A pilot study. Brit. J. Psychiat. 165, 481-485.
45. Oswald, W. D. and Fleischmann, U. M. (1986) Nürnberger-Alters-Inventar. NAI. Psychologisches Institut II, Universität Erlangen-Nürnberg.
46. Pettegrew, J. W., Panchalingam, K., Klunk, W. E., McClure, R. J. and Muenz, L. R. (1994) Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study. Neurobiol. Aging 15, 117-132.
47. Posse, S., Cuenod, C. A. and Le Bihan, D. (1993) Human brain: Proton diffusion MR spectroscopy. Radiology 188, 719-725.
48. Potts, N. L. S., Davidson, J. R. T. and Krishnan, K. R. R. (1993) The role of nuclear magnetic resonance imaging in psychiatric research. J. Clin. Psychiat. 54 (Suppl. 12), 13-18.
49. Renshaw, P. R., Yurgelun-Todd, D. A., Tohen, M., Gruber, S. and Cohen, B. M. (1995) Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am. J. Psychiat. 152, 444-446.
50. 1H spectroscopy. Glutamate and glutamine; myoinositol and related metabolites. NMR Biomed. 4, 59-63.
51. Ross, B., Kreis, R. and Ernst, T. (1992) Clinical tools for the 90s: Magnetic resonance spectroscopy and metabolite imaging. Eur. J. Radiol. 14, 128-140.
52. Sappey-Marinier, D., Calabrese, G., Hetherington, H. P., Fisher, S. N. G., Deicken, R., van Dyke, C., Fein, G. and Weiner, M. W. (1992) Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities. Magn. Reson. Med. 26, 313-327.
53. Sauter, R., Loeffler, W., Bruhn, H. and Frahm, J. (1990) The human brain: Localized H-1 MR spectroscopy at 1.0 T. Radiology 176, 221-224.
54. Shiino, A., Matsuda, M., Morikawa, S., Inubushi, T., Akiguchi, I. and Handa, J. (1993) Proton magnetic resonance spectroscopy with dementia. Surg. Neurol. 39, 143-147.
55. Shonk, T. K., Moats, R. A., Gifford, P., Michaelis, T., Mandigo, J. C., Izumi, J. and Ross, B. D. (1995) Probable Alzheimer disease: Diagnosis with proton MR spectroscopy. Radiology 195, 65-72.
56. 31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease. Neurobiol. Aging 14, 85-92.
57. Tedeschi, G., Righini, A., Bizzi, A., Barnett, A. S. and Alger, J. R. (1995) Cerebral white matter in the centrum semiovale exhibits a larger N-acetyl signal than does gray matter in long echo time 1H-magnetic resonance spectroscopic imaging. Magn. Reson. Med. 33, 127-133.
58. Urenjak, J., Williams, S. R., Gadian, D. G. and Noble, M. (1992) Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59, 55-61.
59. Urenjak, J., Williams, S. R., Gadian, D. G. and Noble, M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13, 981-989.
60. 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann. Neurol. 31, 202-211.
61. Vion-Dury, J., Meyerhoff, D. J., Cozzone, P. J. and Weiner, M. W. (1994) What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J. Neurol. 241, 354-371.
62. Zaudig, M., Mittelhammer, J., Hiller, W., Pauls, A., Thora, C., Morinigo, A. and Mombour, W. (1991) SIDAM - A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol. Med. 21, 225-236.